The supply of many valuable proteins that have potential clinical or industrial use is often
limited by their low natural availability. With the modern advances in genomics, proteomics …

A bottleneck to product development can be reliable expression of active target protein. A
wide array of recombinant proteins in development, including an ever growing number of …

Plants produce an array of peptides as part of their innate defense mechanism against
pathogens. The potential use of these peptides for various therapeutic purposes is …

The recombinant expression of soluble proteins in Escherichia coli continues to be a major
bottleneck in structural genomics. The establishment of reliable protocols for the …

Abstract Systems biology requires knowledge of the absolute amounts of proteins in order to
model biological processes and simulate the effects of changes in specific model …

Heterologous protein expression in Escherichia coli is commonly used to obtain
recombinant proteins for a variety of downstream applications. However, many proteins are …

Each step in the process of gene expression, from the transcription of DNA into mRNA to the
folding and posttranslational modification of proteins, is regulated by complex cellular …

Protein expression in heterologous hosts for functional studies is a cumbersome effort. Here,
we report a superior platform for parallel protein expression in vivo and in vitro. The platform …

Human Hsp70-2 is a chaperone expressed mainly in the nervous system. Up to now, no
study has reported on the recombinant expression of this important human chaperone …

The repeating unit of the C. difficile Toxin A (rARU, also known as CROPS [combined
repetitive oligopeptides]) C-terminal region, was shown to elicit protective immunity against …